| 1 | 
                
                    Crovalimab
                
            
 💬 | 1件:  Crovalimab Crovalimab | 1件:  CROVALIMAB CROVALIMAB | 1件:  C5 C5 💬
 | 11件:  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件:  62 62, 109 💬
 | 
| 2 | 
                
                    Eculizumab
                
            
 💬 | 1件:  Eculizumab Eculizumab | 2件:  ECULIZUMAB ECULIZUMAB; SOLIRIS | 1件:  C5 C5 💬
 | 11件:  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件:  11 11, 13, 14, 61, 62, 109, 222 💬
 | 
| 3 | 
                
                    Iptacopan
                
            
 💬 | 1件:  Iptacopan Iptacopan | 1件:  Iptacopan Iptacopan | 1件:  CFB CFB 💬
 | 3件:  Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 5件:  61 61, 62, 66, 109, 222 💬
 | 
| 4 | 
                
                    Narsoplimab
                
            
 💬 | 1件:  Narsoplimab Narsoplimab | 2件:  MASP-2 antibody MASP-2 antibody; Narsoplimab | 1件:  MASP2 MASP2 💬
 | 3件:  Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 4件:  64 64, 66, 109, 222 💬
 | 
| 5 | 
                
                    Nomacopan
                
            
 💬 | 1件:  Nomacopan Nomacopan | 2件:  COVERSIN COVERSIN; NOMACOPAN | 1件:  C5 C5 💬
 | 11件:  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件:  62 62, 109, 162 💬
 | 
| 6 | 
                
                    Ravulizumab
                
            
 💬 | 1件:  Ravulizumab Ravulizumab | 2件:  Ravulizumab Ravulizumab; Ultomiris | 1件:  C5 C5 💬
 | 11件:  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件:  2 2, 11, 13, 50, 62, 66, 109 💬
 |